Pharmacotherapy in post-stroke rehabilitation
This article is in "Library" - "Therapy" section.
Author:
R.KH. LYUKMANOV, A.A. RIMKEVICHUS, E.V. GNEDOVSKAYA, N.A. SUPONEVA
Research Center of Neurology, Moscow, Russia
Use of Mexidol in the Therapy of Primary Open-angle Glaucoma
This article is in "Library" - "Ophthalmology" section.
Author:
I.A. LOSKUTOV, O.M. ANDRYUKHINA, A.A. KOVRIZHKINA
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Efficacy of Mexidol in patients with type 2 diabetes mellitus with neurological complications
This article is in "Library" - "Neurology" section.
Author:
E.L. PUGACHEVA
Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia
Neurological manifestations of postcovid syndrome
This article is in "Library" - "COVID-19" section.
Author:
P.R. KAMCHATNOV1, R.A. CHEREMIN2, L.A. SKIPETROVA2, A.V. CHUGUNOV1
1N.I. Pirogov Russian National Research Medical University, Moscow, Russia;
2Center of Speech Pathology and Neurorehabilitation, Moscow, Russia
Study of the efficacy and safety of sequential use of the drugs Mexidol and Mexidol FORTE 250 in the treatment of stroke
This article is in "Library" - "Neurology" section.
Author:
S.M. KARPOV1, M.YU. MOROZOVA2, K.A. MURAVYOV2, I.A. VYSHLOVA1, F.S. KANTEMIROVA3
1Stavropol State Medical University, Stavropol, Russia;
2City Clinical Hospital No. 3, Stavropol, Russia;
3Georgievsky Medical Academy, Simferopol, Russia
Generic drugs: benefit/risk ratio
This article is in "Library" section.
Author:
Ushkalova E.A.1, Zyryanov S.K.1,2, Gopienko I.A.1
1Peoples' Friendship University of Russia (RUDN University), Moscow;
2City Clinical Hospital Twenty-Four, Moscow Healthcare Department, Moscow, Russia
Antioxidant activity and toxicity of ethylmethylhydroxypyridine succinate and edaravone: comparative in vitro experiment
This article is in "Library" section.
Author:
A.V. SHCHUL’KIN, YU.V. ABALENIKHINA, P.D. EROKHINA, AND E.N. YAKUSHEVA
Ryazan State Medical University, ul. Vysokovoltnaya 9, Ryazan, 390026 Russia
Original and generic drugs: what does the clinician need to know?
This article is in "Library" section.
Author:
A.V. SHCHULKIN, A.A. FILIMONOVA
Ryazan State Medical University, Ryazan, Russia
The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia
This article is in "Library" section.
Author:
L.A. SHCHEPANKEVICH1,2, YU.A. NIKOLAEV1, E.V. TANEEVA3, M.A. PERVUNINSKAYA1, M.S. SHCHEPANKEVICH1,2
1Federal Research Center of Fundamental and Translational Medicine, Novosibirsk, Russia;
2Novosibirsk State Medical University, Novosibirsk, Russia;
3State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia
Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)
This article is in "Library" section.
Author:
A.I. FEDIN1, V.V. ZAKHAROV2, M.M. TANASHYAN3, E.I. CHUKANOVA1, E.N. MADZHIDOVA4, L.A. SHCHEPANKEVICH5,6, O.D. OSTROUMOVA7
1Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia;
2Sechenov First Moscow Medical University (Sechenov University), Moscow, Russia;
3Scientific Center of Neurology, Moscow, Russia;
4Tashkent Pediatric Medical Institute, Tashkent, Republic of Uzbekistan;
5Novosibirsk State Medical University, Novosibirsk, Russia;
6Federal Research Center for Fundamental and Translational Medicine, Novosibirsk, Russia;
7Russian Medical Academy of Continuous Professional Education, Moscow, Russia